Company Information

  

Address: 13 GAD FEINSTEIN STREET
PARK REHOVOT P.O.B 2100 
City: REHOVOT 
State:  
Zip Code: 76121 
Telephone: 97289311900 

Description of Business

Primary SIC Code: 2870
(As filed with the SEC)  

We are a leading biotechnology company developing novel products for life science markets through the use of a unique Computational Predictive Biology (CPB) platform. 26 -------------------------------------------------------------------------------- Our company was founded on October 10, 1999 as Agro Leads Ltd., a division of Compugen Ltd. In 2002, our company was spun-off as an independent corporation under the laws of the State of Israel, and changed its name to Evogene Ltd. Our shares have been trading on the TASE since 2007, on the NYSE from November 2013 until December 2016, and on the Nasdaq since December 2016. We are registered with the Israeli Registrar of Companies in Jerusalem. Our registration number is 51-283872-3. Our purpose as set forth in our articles of association is to engage in any lawful business.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/2017-0.81NAN/E
12/2016-0.77NAN/E
12/2015-0.68NAN/E
12/2013-0.45NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-146.75Total Liab/Total Assets0.11
Net Inc/Total Assets-0.27Total Liab/Inv Cap0.12
Net Inc/Inv Cap-0.30Total Liab/Comm Equity57.92
Pretax Inc/Net Sales-6.16Interest Coverage Ratio-19.72
Net Inc/Net Sales-6.16Curr Debt/Equity0.04
Cash Flow/Net Sales-4.71LTD/EquityNA
SG&A/NetSales1.63Total Debt/Equity0.04
Asset Utilization   Liquidity  
Net Receivables Turnover2.91Quick Ratio15.61
Inventory TurnoverNACurrent Ratio15.61
Inventory Day SalesNANet Rec/Curr Assets0.01
Net Sales/Work Cap0.05Inv/Curr AssetsNA
Net Sales/PP&E0.71  

Income Statement (Millions)

  12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Revenues(Net Sales) 3.38 6.54 11.13 14.51
Cost of Goods Sold 2.85 5.64 8.26 9.71
Selling & Admin Exps 5.50 5.59 6.35 6.04
Operating Income -21.95 -21.09 -17.92 -15.26
Interest Exp 1.01 0.89 1.86 1.52
Pretax Income -20.83 -19.56 -17.21 -14.53
Other Income 2.13 2.42 2.57 2.24
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -20.84 -19.59 -17.21 -14.53

Balance Sheet (Millions)

Assets 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Cash & Short Term Investments 63.42 75.02 82.08 86.25
Receivables - Total 0.99 1.33 3.70 2.07
Inventories - Total NA NA NA NA
Total Current Assets 72.79 89.49 104.38 118.37
Net Property, Plant & Equipment 4.79 6.48 8.20 8.81
Total Assets 77.60 95.99 112.60 127.59
Liabilities        
Accounts Payable 1.11 1.33 1.77 1.98
Debt in Current Liabilities 2.93 2.80 3.05 3.85
Total Current Liabilities 4.66 5.23 5.64 7.92
Long-Term Debt NA NA NA NA
Total Liabilities 8.22 8.70 8.84 11.50
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.14 0.14 0.14 0.14
Retained Earnings -117.03 -96.19 -76.60 -59.39
Treasury Stock NA NA NA NA
Total Stockholders' Equity 69.38 87.29 103.75 116.08
Total Liabilities and Stockholders' Equity 77.60 95.99 112.60 127.59

Cash Flow Summary (Millions)

Categories 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Cash Provided by Operating Activities -15.93 -11.69 -12.41 -8.90
Net Cash Provided by Investing Activities 15.25 4.03 17.39 -84.03
Net Cash Provided by Financing Activities 0.81 0.66 0.05 2.67

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201317.58-8.88-0.45
12/201414.51-14.53--
12/201511.13-17.21-0.68
12/20166.54-19.59-0.77
12/20173.38-20.84-0.81
Growth Rates-33.78----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18269,19635.71




Report Date : 7/9/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.